Lantern Pharma launches withZeta.ai commercial platform for cancer research Apr 14, 2026 08:36AM
Lantern Pharma Launches withZeta.ai — the World’s First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development — Subscriptions Now Open; Debut Events at Nasdaq MarketSi Apr 14, 2026 08:31AM